References
- 1. Donovan TJ, Zimmerman B. The effect of artificial surface on blood coagulability, with special reference to polyethylene. Blood. 1949;4:1310.
- 2. Vroman L. Methods of investigating protein interaction on artificial and natural surfaces. Ann N Y Acad Sci. 1978;516:300.
- 3. Shepard AD, Gelfand JA, Callow AD, O’Donnell TF Jr. Complement activation by synthetic vascular prostheses. J Vasc Surg. 1984;1:829.
- 4. McCollum CN, Kester RC, Rajah SM, et al. Arterial graft maturation, the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics. Br J Surg. 1981;68:61.
- 5. Kzhyshkowska J, Gudima A, Riabov V, et al. Macrophage responses to implants: Prospects for personalized medicine. J Leukoc Biol. 2015; Published online before print July 13, 2015 doi:10.1189/jlb.5VMR0415-166R. http://www.jleukbio.org/content/early/2015/07/13/jlb.5VMR0415-166R.long
- 6. Swartbol P, Truedsson L, Parsson H, Norgren L. Tumor necrosis factor-α and interleukin-6 release from white blood cells induced by different graft materials In Vitro are affected by pentoxifylline and iloprost. J Biomed Master Res. 1997;36:400.
- 7. Raiter A, Bechor Z, Kleiman M, et al. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model. Eur J Vasc Endovasc Surg. 2010;40(3):381-388.
- 8. Alobaid N, Salacinski HJ, Sales KM, et al. Nanocomposites containing bioactive peptides promote endothelialisation by circulating progenitor cells: An In Vitro evaluation. Eur J Vasc Endovasc Surg. 2006;32(1):76-83.
- 9. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Markers of coagulaton activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2005;29(2):171-176.
- 10. Armitage JD, Lindsey NJ, Homer-Vanniasinkam S. The role of endothelial cell reactive antibodies in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2006;31(2):170-175.
- 11. Daryapeyma A, Pedersen G, Laxdal E, et al. Neutrophil CD64 as a marker for postoperative infection: A pilot study. Eur J Vasc Endovasc Surg. 2009;38(1):100-103.
- 12. Lorenz U, Schäfer T, Ohlsen K, et al. In Vivo detection of Staphylococcus aureus I n biofilm on vascular prostheses using non-invasive biophotonic imaging. Eur J Vasc Endovasc Surg. 2011;41(1):68-75.
- 13. Calligaro KD, Veith FJ, Schwartz ML, Dougherty MJ, DeLaurentis DA. Differences in early versus late extracavitary arterial graft infections. J Vasc Surg. 1995;22(6):680-688.
- 14. Anderson JM. Chapter 4 Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol. 1993;2(3):33-41.
- 15. Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Sem Immunol. 2011;33(3):295-306.
- 16. Anderson JM, Rodriguez A, Chang DT. Innate and adaptive immune responses in tissue engineering. Sem Immunol. 2008;20(2):86-100.
- 17. Geary KJ, Tomkiewicz ZM, Harrison HN, et al. Differential effects of a gram-negative and a gram-positive infection on autogenous and prosthetic grafts. J Vasc Surg. 1990;11(2):339-347.